Valsartan NDMA Lawsuits Cleared To Move Forward, After Motion for Reconsideration Rejected
A federal judge has cleared Valsartan NDMA lawsuits to proceed after rejecting a call by defendants to reconsider the admissibility of plaintiffs' expert witnesses following the recent dismissal of Zantac…